The prescription pattern of initial treatment for type 2 diabetes in Beijing from 2011 to 2015

Medicine
Xiaowen WangYonghua Hu

Abstract

The purpose of this study was to describe the prescription pattern of initial treatment for type 2 diabetes (T2DM) in Beijing from 2011 to 2015.We selected 790,339 newly diagnosed outpatients with T2DM from the Beijing Medical Claim Data for Employees database between January 2011 and December 2015. The percentages of different treatments and agents were calculated from the patients' 1st prescriptions. Subgroup analyses were conducted for primary, secondary, and tertiary hospital settings.The initial treatments given to 57.7%, 30.7%, and 11.7% of patients were oral hypoglycemic agent (OHA) monotherapy, OHA polytherapy, and insulin, respectively. Alpha-glucosidase inhibitors (AGIs) (43.0%) were the most commonly used agents for monotherapy, followed by metformin (35.5%) and sulfonylureas (14.9%). AGIs were most commonly used in primary hospitals (52.0%), while metformin was prescribed most often in secondary (37.6%) and tertiary (41.8%) hospitals. From 2011 to 2015, there were increases in the use of AGIs (40.1-41.1%, P < .001) and metformin (34.0-40.4%, P < .001), but a decrease in the use of sulfonylureas (18.1-12.8%, P < .001). Similar trends were seen in the different hospital settings. Metformin plus an AGI, a sulfonylurea ...Continue Reading

References

May 20, 2011·Clinical Pharmacology and Therapeutics·A G Winterstein
May 27, 2011·Journal of Public Health Policy·Xiaodong GuanLuwen Shi
Nov 1, 2011·Lancet·Dominique Hillaire-BuysJean-Louis Montastruc
Feb 22, 2012·The American Journal of Medicine·Nihar R DesaiNiteesh K Choudhry
Apr 6, 2012·The New England Journal of Medicine·Faramarz Ismail-Beigi
Oct 16, 2012·The American Journal of Medicine·Amishi DesaiBurke A Cunha
Nov 8, 2013·Diabetes Care·Lydia W TurnerG Caleb Alexander
Mar 14, 2014·Diabetes Care·Christian HamppDiane K Wysowski
Apr 9, 2014·BMC Health Services Research·Suvimol NiyomnaithamAlesha J Smith
Jun 26, 2014·Diabetes Care·Tanjala S PurnellNisa Maruthur
Sep 15, 2014·The Lancet. Diabetes & Endocrinology·Wenying Yang, Jianping Weng
Mar 31, 2015·Journal of Pharmaceutical Policy and Practice·Christine Y LuAnita K Wagner
Jun 3, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·A MorR W Thomsen
Dec 27, 2015·European Journal of Clinical Pharmacology·Yiqun WuYonghua Hu
Feb 9, 2016·International Journal of Basic and Clinical Pharmacology·Zuhayer AhmedJesmin Akhter
Apr 8, 2016·BMJ : British Medical Journal·Hugh McGuireUNKNOWN Guideline Development Group
Jul 12, 2016·Medicine·Seung-Hyun KoUNKNOWN Task Force Team for Diabetes Fact Sheet of the Korean Diabetes Association
Dec 14, 2016·The New England Journal of Medicine·Jesus Alegre-DíazJonathan R Emberson
Dec 17, 2016·Diabetes Care·UNKNOWN American Diabetes Association
Feb 14, 2017·Lancet·Sudesna ChatterjeeMelanie J Davies
Feb 28, 2017·European Journal of Internal Medicine·Özcan BaşaranUNKNOWN Collaborators
Mar 28, 2017·Clinical Therapeutics·Jetty A OverbeekRon M C Herings
Apr 4, 2017·The Lancet. Diabetes & Endocrinology·Sophia ZoungasUNKNOWN Collaborators on Trials of Lowering Glucose (CONTROL) group
Jun 28, 2017·JAMA : the Journal of the American Medical Association·Limin WangLinhong Wang
Oct 13, 2017·Current Medical Research and Opinion·Xiao XiangYonghua Hu
Sep 15, 2018·Health Policy and Planning·Shiwei GongSi Jin

❮ Previous
Next ❯

Citations

May 18, 2020·International Journal of Environmental Research and Public Health·Xiaowen WangYonghua Hu
Jan 11, 2020·Endocrinology, Diabetes & Metabolism·Kristy IglayKamlesh Khunti

❮ Previous
Next ❯

Software Mentioned

DiaSTAGE
R
R Development Core Team

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.